BIOMAT Database Logo BIOMAT Database Logo

Thromboelastographic monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency. 2006

Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett

UI MeSH Term Description Entries
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011250 Pregnancy Complications, Hematologic The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS. Complications, Hematologic Pregnancy,Hematologic Pregnancy Complications,Pregnancy Complications, Hematological,Pregnancy, Hematologic Complications,Complication, Hematologic Pregnancy,Complication, Hematological Pregnancy,Complications, Hematological Pregnancy,Hematologic Pregnancy Complication,Hematological Pregnancy Complication,Hematological Pregnancy Complications,Pregnancies, Hematologic Complications,Pregnancy Complication, Hematologic,Pregnancy Complication, Hematological
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002585 Cesarean Section Extraction of the FETUS by means of abdominal HYSTEROTOMY. Abdominal Delivery,Delivery, Abdominal,C-Section (OB),Caesarean Section,Postcesarean Section,Abdominal Deliveries,C Section (OB),C-Sections (OB),Caesarean Sections,Cesarean Sections,Deliveries, Abdominal
D005167 Factor VII Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa. Coagulation Factor VII,Proconvertin,Stable Factor,Blood Coagulation Factor VII,Factor 7,Factor Seven,Factor VII, Coagulation
D005168 Factor VII Deficiency An autosomal recessive characteristic or a coagulation disorder acquired in association with VITAMIN K DEFICIENCY. FACTOR VII is a Vitamin K dependent glycoprotein essential to the extrinsic pathway of coagulation. Hypoproconvertinemia,Deficiency, Factor 7,Deficiency, Factor Seven,Deficiency, Factor VII,Factor 7 Deficiency,Deficiencies, Factor 7,Deficiencies, Factor Seven,Deficiencies, Factor VII,Factor 7 Deficiencies,Factor Seven Deficiencies,Factor Seven Deficiency,Factor VII Deficiencies,Hypoproconvertinemias
D005260 Female Females

Related Publications

Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Treatment of factor VII deficiency with recombinant factor VIIa.
January 1996, Haemostasis,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Factor VII deficiency in pregnancy treated with recombinant factor VIIa.
May 2002, Obstetrics and gynecology,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency.
July 2008, Haemophilia : the official journal of the World Federation of Hemophilia,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
May 2004, Haemophilia : the official journal of the World Federation of Hemophilia,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
January 2000, Seminars in thrombosis and hemostasis,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Thromboelastographic evaluation of recombinant factor VIIa in a child with Glanzmann's thrombasthenia.
September 2006, Anesthesia and analgesia,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.
December 2005, Thrombosis and haemostasis,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Recombinant factor VIIa for long-term replacement therapy in patients with congenital factor VII deficiency.
October 2007, Thrombosis and haemostasis,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Factor VIIa replacement therapy in factor VII deficiency.
October 2004, Journal of thrombosis and haemostasis : JTH,
Nollag O'Rourke, and Christopher Lee, and Bhavani Shankar Kodali, and Miriam Harnett
Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
February 2007, The Journal of bone and joint surgery. American volume,
Copied contents to your clipboard!